Gene · 6523
Papers3,836
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,836
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SGLT2 expression in human vasculature and heart correlates with low-grade inflammation and causes eNOS-NO/ROS imbalance. | Cardiovasc Res | 2025 | 39739876 | PubTator, text mining | PubMed |
| Investigation of glucosuria in children. | Minerva Pediatr (Torino) | 2025 | 39651934 | PubTator, text mining | PubMed |
| Energy-based bond graph models of glucose transport with SLC transporters. | Biophys J | 2025 | 39644093 | PubTator, text mining | PubMed |
| Single-cell transcriptomics of human organoid-derived enteroendocrine cell populations from the small intestine. | J Physiol | 2025 | 39639676 | PubTator, text mining | PubMed |
| Reducing the dietary starch:protein ratios in low-protein diets enhanced the growth performance of goslings from 1 to 28 days of age. | Poult Sci | 2025 | 39622092 | PubTator, text mining | PubMed |
| Transcriptomics of SGLT2-positive early proximal tubule segments in mice: response to type 1 diabetes, SGLT1/2 inhibition, or GLP1 receptor agonism. | Am J Physiol Renal Physiol | 2025 | 39589189 | PubTator, text mining | PubMed |
| Empagliflozin demonstrates cytotoxicity and synergy with tamoxifen in ER-positive breast cancer cells: anti-proliferative and anti-survival effects. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | 39066911 | PubTator, text mining | PubMed |
| Sodium-glucose exchanger 2 inhibitor canagliflozin promotes mitochondrial metabolism and alleviates salt-induced cardiac hypertrophy via preserving SIRT3 expression. | J Adv Res | 2025 | 38744404 | PubTator, text mining | PubMed |
| Rationale and Design of the SOTA-P-CARDIA Trial (ATRU-V): Sotagliflozin in HFpEF Patients Without Diabetes. | Cardiovasc Drugs Ther | 2025 | 37318685 | PubTator, text mining | PubMed |
| A translational framework of genoproteomic studies for cardiovascular drug discovery. | NPJ Cardiovasc Health | 2024 | 41776041 | PubTator, text mining | PubMed |
| Uncovering key genes and molecular mechanisms of dendritic cell dysfunction in Esophageal Cancer: implications for Novel Diagnostic and therapeutic strategies. | Discov Oncol | 2024 | 39692816 | PubTator, text mining | PubMed |
| Sodium-dependent glucose co-transport proteins (SGLTs) are not involved in human glucose taste detection. | PLoS One | 2024 | 39556551 | PubTator, text mining | PubMed |
| Uninephrectomy and sodium-glucose cotransporter 2 inhibitor administration delay the onset of hyperglycemia. | Physiol Rep | 2024 | 39523534 | PubTator, text mining | PubMed |
| Synthesis of a Small Library of Glycoderivative Putative Ligands of SGLT1 and Preliminary Biological Evaluation. | Molecules | 2024 | 39519708 | PubTator, text mining | PubMed |
| The Benefits of Whole-Exome Sequencing in the Differential Diagnosis of Hypophosphatasia. | Int J Mol Sci | 2024 | 39519277 | PubTator, text mining | PubMed |
| Multiple Effects of SGLT2 Inhibitors. | JMA J | 2024 | 39513073 | PubTator, text mining | PubMed |
| The Impact of SGLT1 Inhibition on Frailty and Sarcopenia: A Mediation Mendelian Randomization Study. | J Cachexia Sarcopenia Muscle | 2024 | 39474649 | PubTator, text mining | PubMed |
| Impact of Vitamin D deficiency on immunological and metabolic responses in women with recurrent pregnancy loss: focus on VDBP/HLA-G1/CTLA-4/ENTPD1/adenosine-fetal-maternal conflict crosstalk. | BMC Pregnancy Childbirth | 2024 | 39472874 | PubTator, text mining | PubMed |
| Regulation of Enterocyte Brush Border Membrane Primary Na-Absorptive Transporters in Human Intestinal Organoid-Derived Monolayers. | Cells | 2024 | 39404387 | PubTator, text mining | PubMed |
| SGLT1 inhibition alleviates radiation-induced intestinal damage through promoting mitochondrial homeostasis. | Free Radic Biol Med | 2024 | 39393555 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6523/papers?page=8